← FDA Drug Approvals (Drugs@FDA)
NYSTATIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TARO · Approved 1988-02-29
Drug application
- FDA Application #
ANDA062876- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NYSTATIN
- Generic name
- NYSTATIN
- Active ingredients
- NYSTATIN
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- TARO
- Manufacturer
- Taro Pharmaceuticals U.S.A., Inc.
- First approval
- 1988-02-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown